The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20110789: Baxter International Inc.; Essex Woodlands Health Ventures Fund Vi, L.P.
Dow Chemical Company, The, and Union Carbide Corporation
Dow settled antitrust concerns relating to its proposed merger with Union Carbide Corporation. Dow agreed to divest and license intellectual property necessary to the production of linear low-density polyethylene -an ingredient used in premium plastic products such as trash bags and sealable food pouches -to BP Amoco plc.
Hikma Pharmaceuticals PLC; Analysis of Agreement Containing Consent Orders to Aid Public Comment: Proposed Consent Agreement
Prepared Statement of the Federal Trade Commission On Data Security
FTC Staff Comment to the Hon. Elliot Naishtat Concerning Texas S.B. 8 to Exempt Certified Health Care Collaboratives From the Antitrust Laws
FTC Staff Comment to the Hon. Alice H. Peisch, Massachusetts House of Representatives, Concerning Legislation Imposing Additional Restrictions on Malt Beverage Suppliers and Supplier-Wholesaler Relationships
FTC Comment Before the Federal Communications Commission Regarding Liability for Telemarketing Calls Under the Telephone Consumer Protection Act (TCPA), CG Docket No. 11-50
FTC Staff Letter To The Honorable Rodney Ellis and The Honorable Royce West, The Senate of the State of Texas, Concerning Texas Senate Bills 1260 and 1339 and the Regulation of Advanced Practice Registered Nurses
20110780: Jefferies Group, Inc.; Prudential Financial, Inc.
Decision Not to Take Additional Action With Respect To Representations Made By Hewlett-Packard Regarding Its Printer Ink Cartridges
Hewlett-Packard Co. (HP printer cartridges)
1104012 Informal Interpretation
1104012 Informal Interpretation
Golden Empire Mortgage, Inc., a corporation, et al., FTC
1104011 Informal Interpretation
1104011 Informal Interpretation
Laboratory Corporation of America and Laboratory Corporation of America Holdings, In the Matter of
The FTC challenged Laboratory Corporation of America’s $57.5 million acquisition of rival clinical laboratory testing company Westcliff Medical Laboratories, Inc., alleging that the transaction would lead to higher prices and lower quality in the Southern California market for the sale of clinical laboratory testing services to physician groups. The complaint also alleges that LabCorp’s acquisition of Westcliff would leave only two significant laboratories in Southern California competing to provide critical testing services to most physician groups.The FTC also filed an action in federal court to prevent LabCorp from integrating the Westcliff assets while the case is being tried in the administrative court. The federal court denied the FTC motion for an injunction pending appeal. Staff filed an emergency motion for an injunction pending appeal with the 9th Circuit, which denied the Commission's appeal. The Commission dismissed its complaint and closed the investigation.